Your browser doesn't support javascript.
loading
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 9. The synthesis and biological evaluation of novel simvastatin analogs.
Hartman, G D; Halczenko, W; Duggan, M E; Imagire, J S; Smith, R L; Pitzenberger, S M; Fitzpatrick, S L; Alberts, A W; Bostedor, R; Chao, Y S.
Afiliação
  • Hartman GD; Merck Research Laboratories, West Point, Pennsylvania 19486.
J Med Chem ; 35(21): 3813-21, 1992 Oct 16.
Article em En | MEDLINE | ID: mdl-1433193
ABSTRACT
Substitution of hydroxy and hydroxyalkyl functionality at C-7 of the hexahydronaphthalene nucleus of simvastatin has provided novel analogs. The synthetic strategy employed epoxidation or Lewis acid-catalyzed aldol reaction of the 8-keto silyl enol ether as a key reactive intermediate. These analogs were evaluated as potential hypocholesterolemic agents via initial determination of their ability to inhibit HMG-CoA reductase in vitro. Oral activity of these compounds was determined in an acute rat model and a three-week study in cholestyramine-primed dogs. Compounds were identified that possessed in vitro and in vivo activity comparable to that of simvastatin.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Lovastatina / Inibidores de Hidroximetilglutaril-CoA Redutases / Anticolesterolemiantes Idioma: En Ano de publicação: 1992 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Lovastatina / Inibidores de Hidroximetilglutaril-CoA Redutases / Anticolesterolemiantes Idioma: En Ano de publicação: 1992 Tipo de documento: Article